Impact of Highly Active Antiretroviral Therapy on Chronic Hepatitis B Serological Markers among Senegalese HIV Co-infected Children

  • Ba A
  • Ndiaye F
  • Djeng Y
  • et al.
N/ACitations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Background: Coinfection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) causes complex interactions. The aim of this study was to evaluate the seroprevalence and HBV evolution among HIV coinfected children receiving highly active antiretroviral therapy (HAART). Methods: A descriptive cross-sectional study was carried out among 252 HIV infected children enrolled in the H

Cite

CITATION STYLE

APA

Ba, A., Ndiaye, F. K., Djeng, Y. J., Cames, C., Diack, A., & Ndiaye, O. (2019). Impact of Highly Active Antiretroviral Therapy on Chronic Hepatitis B Serological Markers among Senegalese HIV Co-infected Children. International Journal of Maternal and Child Health and AIDS (IJMA), 8(2), 131–137. https://doi.org/10.21106/ijma.321

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free